Page last updated: 2024-12-05

nitrosoguanidines

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Nitrosoguanidines: Nitrosylated derivatives of guanidine. They are used as MUTAGENS in MOLECULAR BIOLOGY research. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12660
CHEMBL ID447467
MeSH IDM0014922

Synonyms (29)

Synonym
nitrosoguanidines
unii-z0fdz0e0ae
z0fdz0e0ae ,
nitrosoguanidin
wln: onmyzum
nitrosoguanidine
initiating explosive nitrosoguanidine
guanidine, nitroso-
674-81-7
nsc-33670
nsc33670
nsc 33670
ccris 2194
initiating explosive nitrosoguanidine (dot)
nitrosoguanidin [german]
n-nitrosoguanidine
2-nitrosoguanidine
CHEMBL447467
FT-0691141
N0325
AKOS006223226
guanidine, n-nitroso-
alpha-methyllevulinicacid
DTXSID40217756
1-nitrosoguanidine
isonitroso-guanidine
Q27294836
nitrosoguanidine (wetted with ca. 20% water, containing 5g on a dry weight basis),
AKOS040768883

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" From a comparative analysis of 14 dose-response curves for deletions and base changes, we conclude that the order of mutagenic efficiency relative to killing is (EMS, NTG) greater than (UV, 4NQO) greater than HA greater than (X-rays, MTC), and that X-rays, 4NQO, HA and MTC induce more ColBR deletions than Argplus base changes, whereas UV and EMS induce ColBR deletions and Argplus base changes at nearly equal rates and the specificity of NTG is intermediate between these two types."( Comparative analysis of deletion and base-change mutabilities of Escherichia coli B strains differing in DNA repair capacity (wild-type, uvrA-, polA-, recA-) by various mutagens.
Ishii, Y; Kondo, S, 1975
)
0.25
" Dose-response relationships for recombination and mutation are discussed."( Induction of mitotic recombination with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) in Saccharomyces cerevisiae. A comparison between treatment in vitro and in the host-mediated assay.
Ryttman, H; Zetterberg, G, 1976
)
0.26
"N-methyl-N-nitroso-N'-nitroguanidine was administered as drinking water to Wistar strain and non-inbred male rats in the dosage of 100 mKg/ml for 7 months, Adenocarcinomas of the stomach were produced in about 70% of rats."( [Induction of stomach tumors in rats by N-methyl-N-nitroso-N1-nitroguanidine].
Bykorez, AI; Kartasheva, LA, 1975
)
0.25
" In trials using 50 microM CyanoDMNG (5 mL dosing solutions), it was demonstrated that hepatocytes are capable of denitrosating a 40 microM concentration of the applied compound with little change in the total or oxidized glutathione levels."( Denitrosation of 1,3-dimethyl-2-cyano-1-nitrosoguanidine in rat primary hepatocyte cultures.
Belka, GK; Dworkin, C; Jensen, DE, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID357532Mutagenic activity in Salmonella Typhimurium TA100 assessed as number of spontaneous revertants at 10 ug/plate by Ames test in presence of rat liver microsomal S9 fraction
AID357531Mutagenic activity in Salmonella Typhimurium TA100 assessed as number of spontaneous revertants at 10 ug/plate by Ames test in absence of rat liver microsomal S9 fraction
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,049)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990958 (91.33)18.7374
1990's45 (4.29)18.2507
2000's28 (2.67)29.6817
2010's15 (1.43)24.3611
2020's3 (0.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 7.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index7.13 (24.57)
Research Supply Index7.00 (2.92)
Research Growth Index4.12 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (7.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews19 (1.74%)6.00%
Case Studies2 (0.18%)4.05%
Observational0 (0.00%)0.25%
Other1,070 (98.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]